Paradigm BiopharmaceuticalsPAR 
$0.16-4.08%24h
-4.08%24h
Global rank24580
Market cap$46.05M
Change 7d0.00%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.63K
Earnings-$35.12M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals (PAR) Cash on Hand
PAR Cash on Hand in 2022: $38.11M
According to Paradigm Biopharmaceuticals latest financial reports the cash on hand of PAR is $38.11M, an increase of 41.99% to 2022. At the end of 2022 company had $26.84M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
PAR Cash on Hand History from 2019 to 2023
-
Value:-
PAR Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $38.11M | 41.99% |
| 2022 | $26.84M | -44.15% |
| 2021 | $48.06M | -31.65% |
| 2020 | $70.31M | 31.82% |
| 2019 | $53.34M | - |
View the Top Cash on Hand Companies 
